Nascent Biotech, Inc.
NBIO · OTC
3/31/2024 | 3/31/2023 | 3/31/2022 | 3/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $372 | $172 | $94 | $1 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $750 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $180 | $83 | $11 | $0 |
| Total Curr. Assets | $552 | $255 | $105 | $751 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $0 | $0 | $0 | $0 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $552 | $255 | $105 | $751 |
| Liabilities | – | – | – | – |
| Payables | $686 | $498 | $777 | $538 |
| Short-Term Debt | $123 | $390 | $0 | $162 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $123 |
| Other Curr. Liab. | $0 | $663 | $0 | $401 |
| Total Curr. Liab. | $809 | $1,551 | $777 | $1,224 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $777 | $799 |
| Other Liabilities | $0 | $0 | -$777 | -$799 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $809 | $1,551 | $777 | $1,224 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $171 | $132 | $111 | $105 |
| Retained Earnings | -$24,260 | -$21,623 | -$18,822 | -$18,351 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $23,833 | $20,195 | $18,039 | $17,774 |
| Total Equity | -$257 | -$1,296 | -$671 | -$473 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $552 | $255 | $105 | $751 |
| Net Debt | -$250 | $217 | -$94 | $160 |